<DOC>
	<DOCNO>NCT02674854</DOCNO>
	<brief_summary>To evaluate ocular hypotensive efficacy safety PG324 Ophthalmic Solution compare netarsudil ( AR-13324 ) ophthalmic solution 0.02 % latanoprost ophthalmic solution 0.005 %</brief_summary>
	<brief_title>Double-masked Study PG324 Ophthalmic Solution Patients With Open-angle Glaucoma Ocular Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>1 . 18 year age old ( 19 year age old Canada ) 2 . Diagnosis open angle glaucoma ocular hypertension eye 3 . Unmedicated intraocular pressure &gt; 20mmHg &lt; 36mmHg eye 2 qualification visit 4 . Corrected visual acuity equivalent 20/200 5 . Able give inform consent follow study instruction 1 . Clinically significant ocular disease 2 . Pseudoexfoliation pigment dispersion component glaucoma , history angle closure narrow angle 3 . Unmedicated intraocular pressure ≥36mmHg 4 . Use 2 ocular hypotensive medication within 30 day screen 5 . Known hypersensitivity component formulation 6 . Previous glaucoma surgery refractive surgery 7 . Ocular trauma within 6 month prior screen 8 . Any ocular surgery nonrefractive laser treatment within 3 month prior screen 9 . Recent current ocular infection inflammation either eye 10 . Used ocular medication either eye kind within 30 day screen 11 . Mean central corneal thickness &gt; 620µm screen 12 . Any abnormality prevent reliable applanation tonometry either eye 13 . Clinically significant abnormality lab test screen 14 . Clinically significant systemic disease 15 . Participation investigational study within 30 day prior screen 16 . Used systemic medication could substantial effect intraocular pressure within 30 day prior screen 17 . Women pregnant , nursing , plan pregnancy use medically acceptable form birth control</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>